J. Bissonnette

Development of a Center for Personalized Cancer Care at a Regional Cancer Center: Feasibility Trial of an Institutional Tumor Sequencing Advisory Board.

B. Lane, D. Chesla, S. Cottingham, 2015, The Journal of molecular diagnostics : JMD.

Apparently Heterozygous TP53 Pathogenic Variants May Be Blood-Limited in Patients Undergoing Hereditary Cancer Panel Testing.

K. Postula, J. Mester, K. Hruska, 2019, The Journal of molecular diagnostics : JMD.

Estimation of ENPP1 deficiency genetic prevalence using a comprehensive literature review and population databases

C. Ferreira, F. Rutsch, M. Kiel, 2022, Orphanet Journal of Rare Diseases.

Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing

Wendy K Chung, W. Chung, S. Bale, 2015, Genetics in Medicine.